T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Arista Networks
ANET
$265B
| $4.87B | 0.53% |
37,171,766
+380,724
| +1% | +$52.4M |
|
27
Chubb
CB
$132B
| $4.67B | 0.5% |
14,947,799
+3,049,987
| +26% | +$892M |
|
28
AstraZeneca
AZN
$246B
| $4.47B | 0.48% |
24,321,914
-240,324
| -1% | -$42.1M |
|
29
Thermo Fisher Scientific
TMO
$223B
| $4.46B | 0.48% |
7,701,353
+1,230,872
| +19% | +$696M |
|
30
Advanced Micro Devices
AMD
$788B
| $4.35B | 0.47% |
20,325,288
+55,969
| +0.3% | +$12.6M |
|
31
Procter & Gamble
PG
$335B
| $4.24B | 0.46% |
29,612,826
+1,091,091
| +4% | +$161M |
|
32
Linde
LIN
$221B
| $4.17B | 0.45% |
9,784,371
+695,771
| +8% | +$298M |
|
33
ConocoPhillips
COP
$153B
| $4.1B | 0.44% |
43,841,348
+36,952
| +0.1% | +$3.34M |
|
34
Applovin
APP
$102B
| $4.1B | 0.44% |
6,089,735
+212,349
| +4% | +$134M |
|
35
Citigroup
C
$231B
| $3.98B | 0.43% |
34,103,871
-1,681,282
| -5% | -$175M |
|
36
Intuit
INTU
$91.6B
| $3.88B | 0.42% |
5,854,645
-469,231
| -7% | -$310M |
|
37
Shopify
SHOP
$194B
| $3.79B | 0.41% |
23,531,422
-2,901,717
| -11% | -$466M |
|
38
ExxonMobil
XOM
$657B
| $3.74B | 0.4% |
31,037,919
-526,997
| -2% | -$61.1M |
|
39
Danaher
DHR
$145B
| $3.66B | 0.39% |
15,973,240
+1,334,221
| +9% | +$293M |
|
40
Home Depot
HD
$342B
| $3.65B | 0.39% |
10,616,042
+213,060
| +2% | +$78M |
|
41
Oracle
ORCL
$442B
| $3.59B | 0.39% |
18,425,292
-2,389,329
| -11% | -$569M |
|
42
Deere & Co
DE
$167B
| $3.58B | 0.39% |
7,692,877
+158,584
| +2% | +$74.4M |
|
43
Stryker
SYK
$133B
| $3.56B | 0.38% |
10,118,064
-879,884
| -8% | -$321M |
|
44
Keysight
KEYS
$60.6B
| $3.54B | 0.38% |
17,419,811
+85,693
| +0.5% | +$15.9M |
|
45
Caterpillar
CAT
$393B
| $3.43B | 0.37% |
5,993,729
-818,801
| -12% | -$455M |
|
46
Howmet Aerospace
HWM
$112B
| $3.41B | 0.37% |
16,632,206
+3,531,700
| +27% | +$703M |
|
47
Gilead Sciences
GILD
$168B
| $3.4B | 0.37% |
27,698,660
+1,195,269
| +5% | +$145M |
|
|
48
KLA
KLAC
$272B
| $3.29B | 0.35% |
27,049,730
+11,858,290
| +78% | +$1.39B |
|
49
Mercado Libre
MELI
$92.7B
| $3.19B | 0.34% |
1,583,071
+137,100
| +9% | +$288M |
|
50
DoorDash
DASH
$92.1B
| $3.16B | 0.34% |
13,958,114
+3,447,754
| +33% | +$809M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.